Point-of-Care Molecular System
Accurate. Accessible. Actionable.
Simplifying PCR, transforming healthcare.
What We Do
We design, manufacture and commercialize next generation molecular diagnostic tests, bringing the superior diagnostics performance of PCR to the point-of-care (POC).
We strive to bring DNA and RNA testing to a much larger population segment than alternative, legacy solutions so healthcare providers can more effectively treat patients.
Our proprietary OSCAR technology is key to our patented and patent-pending diagnostic solutions. Our revolutionary technology offers the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays while providing the superior sensitivity, specificity of laboratory-based molecular testing.
The PCR test technology developed by Mesa Biotech enables healthcare professionals to access actionable, laboratory-quality results at the Point of Care:
Mesa Biotech’s Accula System consists of a portable, palm-sized dock and assay-specific test cassettes
Superior diagnostics performance of nucleic acid PCR
Near patient results to start effective treatment
Accula FluA/B and Accula RSV are CE Marked, 510 (K) cleared and CLIA Waived